Liftstream is an executive search recruitment company in the life sciences sector
Rigel Appoints Chief Medical Officer
Rigel Pharmaceuticals, a clinical-stage biotechnology company focused on immunology, oncology and immuno-oncology, has appointed Anne-Marie Duliege as chief medical officer to replace Elliott Grossbard, who is to retire after 14 years of service. Grossbard will remain with the company, advising on the new drug application (NDA) filing and regulatory strategy for fostamatinib in immune thrombocytopenic purpura (ITP).
Carole Ho appointed as CMO and Development Head at Denali
Denali Therapeutics, a San Francisco based biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that Carole Ho, M.D., has joined the company as Chief Medical Officer and Head of Development. In this role, Dr. Ho will lead the translational and clinical development activities at Denali and serve on the Executive Leadership Team.
OXiGENE Appoints Matthew M. Loar as Chief Financial Officer
OXiGENE, Inc. (Nasdaq:OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, announced that Matthew M. Loar has been appointed Chief Financial Officer. Mr. Loar is a seasoned financial executive with over 20 years of financial and accounting experience in both public and private companies in the biopharmaceutical industry.
What does it take to reach and succeed at the ‘C’ and Board level?
Liftstream has been collaborating with two organisations to put together a key leadership meeting on gender diversity in biotechnology. The event is based on our published research and we have worked with our network of executives to bring about an incredible panel of industry leaders.
Onyx deal signals broader interest in orphan drugs
Authored by Karl Simpson